VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 799 · 114th Congress

Protecting Our Infants Act of 2015

Law · 114-91 · Nov 25, 2015
Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Became law without a recorded vote. It passed by voice vote or unanimous consent, which don't record how each member voted.

MMR McConnellSponsor
22 cosponsors · 9 D, 12 R, 1 I
  1. Senate Introduced Mar 19, 2015
  2. Senate Passed Oct 22, 2015
  3. House Passed Nov 16, 2015
  4. President To the President Nov 19, 2015
  5. President Signed Nov 25, 2015
  6. Law Nov 25, 2015
What it does: CRS summary · Public Law · Nov 25, 2015

(This measure has not been amended since it was reported to the Senate on October 1, 2015. The summary of that version is repeated here.)

Protecting Our Infants Act of 2015

(Sec. 2) This bill requires the Department of Health and Human Services (HHS) to review its activities related to prenatal opioid use, including neonatal abstinence syndrome, and develop a strategy to address gaps in research and gaps and overlap in programs. (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications. Neonatal abstinence syndrome is withdrawal in a newborn.)

(Sec. 3) HHS must conduct a study and develop recommendations for preventing and treating prenatal opioid use disorders, including the effects of those disorders on infants. HHS must publish a report that includes:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age and recommendations on preventing opioid use disorders in these women;
  • an evaluation of, and recommendations on, treatment for pregnant women with opioid use disorders and the effects of prenatal opioid use on infants; and
  • an evaluation of the differences in prenatal opioid use between demographic groups and recommendations on reducing disparities.
(Sec. 4) HHS may continue providing technical assistance: (1) to states and Indian tribes to improve neonatal abstinence syndrome surveillance; and (2) to states to support implementation of effective public health measures, such as disseminating information to educate the public on prenatal opioid use and neonatal abstinence syndrome.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Protecting Our Infants Act of 2015

Latest action (Nov 25, 2015): Became Public Law No: 114-91.

Policy area: Health · Origin: Senate · Introduced: Mar 19, 2015

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

  1. Senate Introduced Mar 19, 2015
  2. Senate Passed Oct 22, 2015
  3. House Passed Nov 16, 2015
  4. President To the President Nov 19, 2015
  5. President Signed Nov 25, 2015
  6. Law Nov 25, 2015

No recorded floor vote found.